TargetMol

Rufinamide

Product Code:
 
TAR-T2523
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2523-5mg5mg£97.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2523-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2523-10mg10mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2523-25mg25mg£146.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2523-50mg50mg£193.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2523-100mg100mg£292.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2523-200mg200mg£401.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2523-500mg500mg£611.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Rufinamide, a triazole derivative, is used as voltage-gated sodium channel blocker for the treatment of seizure disorders.
CAS:
106308-44-5
Formula:
C10H8F2N4O
Molecular Weight:
238.198
Pathway:
Membrane transporter/Ion channel
Purity:
0.9989
SMILES:
NC(=O)c1cn(Cc2c(F)cccc2F)nn1
Target:
Sodium Channel

References

1. Cheng-Hakimian A, et al. Int J Clin Pract,2006, 60(11), 1497-1501. 2. Williams ET, et al. Drug Metab Lett,2011, 5(4), 280-289. 3. Wright HM, et al. J Vet Pharmacol Ther,2012, 35(6), 529-533. 4. Suter MR, et al. Anesthesiology,2013, 118(1), 160-172. 5. White HS, et al. Epilepsia,2008, 49(7), 1213-1220.